Immunopathogenesis and treatment of cytokine storm in COVID-19
COVID-19에서 면역 병인 및 사이토 카인 폭풍의 치료
Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
addition
Anakinra
Anti-inflammatory therapy
anti-inflammatory treatment
anti-inflammatory treatments
approach
Baricitinib
caused
characterized
clinical condition
clinical conditions
clinical evidence
comparison
Comparisons
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 cytokine storm
COVID-19 infection
cytokine
cytokine blockades
Cytokine release syndrome
cytokine removal
Cytokine storm
Cytokines
drug
early stage
hemophagocytic lymphohistiocytosis
hyper-inflammation
IFN
IL-1
IL-6
immune reaction
indicated
involved
multiple organ failure
Pathogenesis
Patient
plasma exchange
recent
recommendation
respiratory distress
severe coronavirus disease
severe COVID-19
shown
syndrome
systemic hyper-inflammation
the cytokine storm
therapeutic
Therapies
Tocilizumab
treat
Treatment
while
with COVID-19
[DOI] 10.7150/thno.49713 PMC 바로가기 [Article Type] Review
[DOI] 10.7150/thno.49713 PMC 바로가기 [Article Type] Review